Target Blood Pressure Level in Diabetes Mellitus Type 2: Evaluation of the Scientific Evidence

Authors

  • Yu.N. Sirenko State Institution «National Scientific Center «Institute of Cardiology named after N.D. Strazhesko» of National Academy of Medical Sciences of Ukraine», Kyiv, Ukraine

DOI:

https://doi.org/10.22141/2307-1257.0.1.3.2013.85331

Keywords:

blood pressure, diabetes mellitus, hypertension

Abstract

The review of the scientific evidence on the control of blood pressure (BP) in patients with diabetes mellitus is given. Their analysis suggests that the optimal level of blood pressure to prevent the development of cardiovascular complications in patients with diabetes mellitus is systolic blood pressure 130–135 mmHg, diastolic blood pressure — < 80 mmHg, and not < 140 mmHg, as it’s indicated in 2012 European Guidelines on cardiovascular disease prevention.

Downloads

Download data is not yet available.

References

European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice // Eur. Heart J. — 2012. — Vol. 33(13). — P. 1635-1701.

Артеріальна гіпертензія. Оновлена та адаптована клінічна настанова, заснована на доказах. Додаток до Наказу МОЗ України № 384 від 24.05.2012 «Про затвердження та впровадження медико­-технологічних документів зі стандартизації медичної допомоги при артеріальній гіпертензії» // www.moz.gov.ua/ua/portal/dn_20120524_384.html

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. US Department of Health and Human Service. NIH Publication No. 03­5233, 2003. — 34 p.

2007 European Society of Hypertension — European Society of Cardiology guidelines for management of arterial hypertension // J. Hypertension. — 2007. — Vol. 25. — P. 1105­-1187.

UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group // BMJ. — 1998. — Vol. 317. — P. 703-­713.

Hansson L., Zanchetti A., Carruthers S.G. et al. the HOT Study Group // The Lancet. — 1998. — Vol. 351. — P. 1755­-1762.

ADVANCE Collaboration // Lancet. — 2007. — Vol. 370. — P. 829­-840.

The ACCORD Study Group // N. Engl. J. Med. — 2010. — Vol. 362. — P. 1575­-1585.

Bangalore S. et al. Blood Pressure Targets in Subjects With Type 2 Diabetes Mellitus/Impaired Fasting Glucose // Circulation. — 2011. — Vol. 123. — P. 2799­-2810.

Redon J., Mancia G., Sleight P. et al. // J. Am. Coll. Cardiol. — 2012. — Vol. 59. — P. 74­-83.

Cederholm J., Gudbjornsdottir S., Eliasson B. et al. on behalf of NDR // J. Hypertension. — 2012. — Vol. 30. — P. 2020­-2030.

Маньковский Б. Распространенность артериальной гипертензии и контроль АД у больных СД 2 типа: результаты исследования ДИАГНОЗ // Ліки України. Діабет і серце. — 2011. — № 6(152).

Downloads

Published

2022-02-15

How to Cite

Sirenko, Y. (2022). Target Blood Pressure Level in Diabetes Mellitus Type 2: Evaluation of the Scientific Evidence. KIDNEYS, (1.3), 7–11. https://doi.org/10.22141/2307-1257.0.1.3.2013.85331

Issue

No. 1.3 (2013)

Section

Guest Articles

License

Copyright (c) 2016 Yu.N. Sirenko

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.